[{"Assets_0_Q3_USD":161657000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-24151000.0,"NetIncomeLoss_1_Q3_USD":-14192000.0,"NetIncomeLoss_3_Q3_USD":-41359000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":134326000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":130199000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":134326000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":130199000.0,"StockholdersEquity_0_Q3_USD":91801000.0,"EarningsPerShareBasic_1_Q3_USD":-0.11,"EarningsPerShareBasic_3_Q3_USD":-0.32,"EarningsPerShareDiluted_1_Q3_USD":-0.11,"EarningsPerShareDiluted_3_Q3_USD":-0.32,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":15399000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":44383000.0,"Ticker":"CERS","CIK":"1020214","name":"CERUS CORP","OfficialName":"Cerus Corporation Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"830388885.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20181101"}]